Riverview Trust Company’s ResMed RMD Stock Holding History

Riverview Trust Company’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-210	Closed	-$47K	–	511
2025 Q1	$47K	Sell	210 -4	-2%	-$934	0.05%	233
2024 Q4	$48.9K	Hold	214	–	–	0.04%	227
2024 Q3	$52.2K	Buy	214 +4	+2%	+$894	0.05%	229
2024 Q2	$40.2K	Hold	210	–	–	0.04%	258
2024 Q1	$41.6K	Buy	+210	New	+$38.5K	0.03%	272
2023 Q4	–	Sell	-210	Closed	-$31.1K	–	522
2023 Q3	$31.1K	Buy	210 +151	+256%	+$27.3K	0.03%	295
2023 Q2	$12.9K	Hold	59	–	–	0.01%	634
2023 Q1	$12.9K	Hold	59	–	–	0.01%	605
2022 Q4	$12K	Hold	59	–	–	0.01%	632
2022 Q3	$13K	Buy	+59	New	+$13.4K	0.01%	531
2022 Q2	–	Sell	-98	Closed	-$24K	–	837
2022 Q1	$24K	Buy	+98	New	+$23.7K	0.02%	409

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Riverview Trust Company's RMD Position: Q2 2025 in Review

Riverview Trust Company sold out of ResMed (RMD) in Q2 2025, closing a stake of 210 shares — an estimated $47K sold.

Riverview Trust Company first reported a position in RMD in Q1 2022 and held it in 11 quarters. The position peaked at $52.2K in Q3 2024. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

Riverview Trust Company reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
Riverview Trust Company sold 210 ResMed shares in Q2 2025, an estimated $47K.
Riverview Trust Company first reported a position in ResMed in Q1 2022 and held it in 11 quarters.
Riverview Trust Company's ResMed position peaked at $52.2K in Q3 2024.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Riverview Trust Company's 13F filing for Q2 2025, filed 21 Jul 2025.